Annette Katelaris: Stroke — for richer or poorer

Jane McCredie: The tightrope of reporting

Martin Van Der Weyden: From the sidelines

Matthew Large

Wendy Lipworth: Counting the cost of off-label prescribing

Jane McCredie: Law shuts down criticisms

Annette Katelaris: Research fraud ― where to from here?

Alasdair Millar: Why QI is a waste of money

Bill Runciman: Why QI is worth it

Jane McCredie: When religion and medicine collide

Hannah Dahlen: Collaboration or control?

John Dixon: Beware the lure of new treatments